1. Home
  2. NAMSW vs FRMEP Comparison

NAMSW vs FRMEP Comparison

Compare NAMSW & FRMEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • FRMEP
  • Stock Information
  • Founded
  • NAMSW N/A
  • FRMEP N/A
  • Country
  • NAMSW Netherlands
  • FRMEP United States
  • Employees
  • NAMSW 29
  • FRMEP 2162
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • FRMEP Major Banks
  • Sector
  • NAMSW Health Care
  • FRMEP Finance
  • Exchange
  • NAMSW Nasdaq
  • FRMEP Nasdaq
  • Market Cap
  • NAMSW N/A
  • FRMEP N/A
  • IPO Year
  • NAMSW N/A
  • FRMEP N/A
  • Fundamental
  • Price
  • NAMSW $8.80
  • FRMEP $25.31
  • Analyst Decision
  • NAMSW
  • FRMEP
  • Analyst Count
  • NAMSW 0
  • FRMEP 0
  • Target Price
  • NAMSW N/A
  • FRMEP N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • FRMEP N/A
  • Earning Date
  • NAMSW N/A
  • FRMEP N/A
  • Dividend Yield
  • NAMSW N/A
  • FRMEP N/A
  • EPS Growth
  • NAMSW N/A
  • FRMEP N/A
  • EPS
  • NAMSW N/A
  • FRMEP N/A
  • Revenue
  • NAMSW N/A
  • FRMEP N/A
  • Revenue This Year
  • NAMSW N/A
  • FRMEP N/A
  • Revenue Next Year
  • NAMSW N/A
  • FRMEP N/A
  • P/E Ratio
  • NAMSW N/A
  • FRMEP N/A
  • Revenue Growth
  • NAMSW N/A
  • FRMEP N/A
  • 52 Week Low
  • NAMSW N/A
  • FRMEP N/A
  • 52 Week High
  • NAMSW N/A
  • FRMEP N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 44.39
  • FRMEP 54.66
  • Support Level
  • NAMSW $9.40
  • FRMEP $25.25
  • Resistance Level
  • NAMSW $10.14
  • FRMEP $25.44
  • Average True Range (ATR)
  • NAMSW 0.36
  • FRMEP 0.04
  • MACD
  • NAMSW -0.05
  • FRMEP 0.01
  • Stochastic Oscillator
  • NAMSW 3.25
  • FRMEP 70.78

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About FRMEP First Merchants Corporation Depository Shares

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: